Načítá se...
Real‐world prevalence of the inclusion criteria for the LEADER trial: Data from a national general practice network
AIMS: To explore the prevalence and describe the clinical characteristics of people with type 2 diabetes with a similar cardiovascular (CV) profile to that of the LEADER trial participants in a primary care setting in England. MATERIALS AND METHODS: In this cross‐sectional analysis, using the Royal...
Uloženo v:
| Vydáno v: | Diabetes Obes Metab |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Blackwell Publishing Ltd
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6619442/ https://ncbi.nlm.nih.gov/pubmed/30900349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13710 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|